Circulating <scp>CD22</scp>+/<scp>CD19</scp>−/<scp>CD24</scp>− progenitors and <scp>CD22</scp>+/<scp>CD19</scp>+/<scp>CD24</scp>− mature B cells: Diagnostic pitfalls for minimal residual disease detection in <scp>B‐lymphoblastic</scp> leukemiaTing Zhou, Hao‐Wei Wang, James N. Kochenderfer et al.|Cytometry Part B Clinical Cytometry|2022Cited by 9
<i>CRLF2</i> -rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapySara Silbert, Nirali N. Shah, Samantha Scanlon et al.|Journal for ImmunoTherapy of Cancer|2024Cited by 8